BridgeBio Pharma BBIO has become a harder stock to judge after its sharp rare-disease run. Attruby is ramping quickly, yet the valuation already assumes a good deal of future success.

The key

BridgeBio Pharma BBIO is moving from a launch-driven story toward a broader commercial execution test. Attruby has quickly become the company’s financial backbone, while late-stage pipeline assets

Investors in BrightView Holdings, Inc. BV need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 15, 2027 $7.50 Call had some of the highest

Investors in HCA Healthcare, Inc. HCA need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 15, 2027 $150 Call had some of the highest implied

TechnipFMC plc FTI, a leading manufacturer and supplier of products and services to the energy sector, announced that it has been awarded a new contract by Eni S.p.A E, an Italian integrated energy

Zebra Technologies Corporation ZBRA is witnessing growth across the healthcare, manufacturing and retail & ecommerce end markets. Higher sales of mobile computing solutions are driving the company’s

ON Semiconductor ON or onsemi recently announced an agreement to divest its Tarlac, Philippines, manufacturing facility to Greatek Electronics and its Mountain Top, PA, facility to Silex

What Does Marvell Do?

Marvell Technology (MRVL) is a leading AI infrastructure company that powers the backend of AI data centers. To train AI models, thousands of GPUs are grouped together. Moving